These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 17237864)

  • 21. Heart failure update: treatment of heart failure with a normal left ventricular ejection fraction in the elderly.
    Aronow WS
    Geriatrics; 2006 Aug; 61(8):16-20. PubMed ID: 16901193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Systolic heart failure in the elderly].
    Kilter H; Böhm M
    Dtsch Med Wochenschr; 2005 Mar; 130(12):698-703. PubMed ID: 15776354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological treatment of chronic heart failure according to the 2005 guidelines of the European Society of Cardiology.
    Voors AA; van Veldhuisen DJ
    Minerva Cardioangiol; 2005 Aug; 53(4):233-9. PubMed ID: 16177668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacotherapy of chronic heart failure].
    Hoppe UC
    Z Arztl Fortbild Qualitatssich; 2003 Apr; 97(2):113-9. PubMed ID: 12806816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacotherapy for heart failure with left ventricular dysfunction: beyond angiotensin-converting enzyme inhibitors and beta-blockers.
    Norgard NB; Stark JE
    Pharmacotherapy; 2008 Jul; 28(7):920-31. PubMed ID: 18576907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure.
    Kazi D; Deswal A
    Cardiol Clin; 2008 Feb; 26(1):1-14, v. PubMed ID: 18312901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacological treatment of chronic heart failure in patients with renal failure].
    Stawicki S; Starczewska MH; Roik M; Opolski G
    Kardiol Pol; 2005 Mar; 62(3):254-60. PubMed ID: 15830021
    [No Abstract]   [Full Text] [Related]  

  • 28. Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF.
    Yancy CW; Fonarow GC; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Am Heart J; 2009 Apr; 157(4):754-62.e2. PubMed ID: 19332206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacotherapy of chronic heart failure in clinical practice].
    Halawa B
    Pol Merkur Lekarski; 2004 Apr; 16(94):307-12. PubMed ID: 15517921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Elderly heart failure patients and the role of beta-blocker therapy].
    Middeljans-Tijssen CW; Jansen RW
    Tijdschr Gerontol Geriatr; 2006 Apr; 37(2):67-77. PubMed ID: 16704019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
    J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric heart failure.
    Picchio FM; Formigari R; Balducci A
    Minerva Cardioangiol; 2008 Jun; 56(3):311-9. PubMed ID: 18509292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
    Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing congestive heart failure in a general hospital in Malaysia. Are we keeping pace with evidence?
    Chin SP; Sapari S; How SH; Sim KH
    Med J Malaysia; 2006 Aug; 61(3):278-83. PubMed ID: 17240575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal treatment of hypertension with diastolic heart failure.
    Susic D; Frohlich ED
    Heart Fail Clin; 2008 Jan; 4(1):117-24. PubMed ID: 18313629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of chronic heart failure in the child].
    Bonnet D
    Arch Pediatr; 2001 Dec; 8(12):1379-82. PubMed ID: 11811037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Triple/quadruple therapy in heart failure: integrating scientific evidence with clinical reasoning].
    Sinagra G; Sabbadini G; Zecchin M; Di Lenarda A
    G Ital Cardiol (Rome); 2007 Sep; 8(9):559-67. PubMed ID: 17972425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managing hypertension using combination therapy.
    Frank J
    Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blocking the renin-angiotensin system: dual- versus mono-therapy.
    Ravandi A; Teo KK
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.